Published in Int J Cardiovasc Imaging on February 14, 2010
Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging (2014) 0.97
Stress imaging in patients with diabetes; routine practice? Int J Cardiovasc Imaging (2010) 0.80
Long-term prognostic value of dobutamine stress echocardiography in diabetic patients with limited exercise capability: a 13-year follow-up study. Diabetes Care (2012) 0.78
Cardiovascular imaging 2010 in the International Journal of Cardiovascular Imaging. Int J Cardiovasc Imaging (2011) 0.76
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol (2002) 4.11
Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care (1998) 3.34
Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr (1998) 1.92
Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol (1997) 1.72
Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol (2002) 1.57
Revascularization in severe left ventricular dysfunction: the role of viability testing. J Am Coll Cardiol (2005) 1.42
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation (1997) 1.38
Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care (2001) 1.37
Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J (2001) 1.24
The Verona diabetes study: a population-based survey on known diabetes mellitus prevalence and 5-year all-cause mortality. Diabetologia (1995) 1.21
Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care (2002) 1.08
Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care (2001) 1.05
Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation (1998) 1.04
Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. Eur J Vasc Endovasc Surg (2005) 1.01
Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia (1999) 1.01
Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care (2003) 0.94
Dobutamine stress echocardiography in patients with diabetes mellitus: enhanced prognostic prediction using a simple risk score. J Am Coll Cardiol (2006) 0.94
Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol (1997) 0.94
Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol (2003) 0.90
Prognostic role of dobutamine stress echocardiography in myocardial viability. Curr Opin Cardiol (2006) 0.78
Stress echocardiography for risk stratification of asymptomatic patients with type 2 diabetes mellitus. Int J Cardiol (2007) 0.78
Dobutamine stress echocardiography response of asymptomatic patients with diabetes. Echocardiography (2001) 0.75
Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc (2009) 2.28
Hypertension and reduced renal function in an 83-year-old patient. Intern Emerg Med (2006) 1.92
Subtle neurological abnormalities as risk factors for cognitive and functional decline, cerebrovascular events, and mortality in older community-dwelling adults. Arch Intern Med (2008) 1.71
Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol (2006) 1.70
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol (2011) 1.60
Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care (2010) 1.60
DPP-4 inhibitors and lipids: systematic review and meta-analysis. Adv Ther (2011) 1.59
Dipeptidyl peptidase-4 inhibitors and bone fractures: a meta-analysis of randomized clinical trials. Diabetes Care (2011) 1.58
Sulphonylureas and cancer: a case-control study. Acta Diabetol (2008) 1.56
Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med (2010) 1.54
Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials. Curr Med Res Opin (2011) 1.48
Management of acute myocardial infarction in the real world: a summary report from The Ami-Florence Italian Registry. Intern Emerg Med (2008) 1.48
Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin. Diabetes Metab Res Rev (2006) 1.47
The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. J Sex Med (2010) 1.46
Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry (2013) 1.45
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf (2014) 1.44
The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study. J Am Coll Cardiol (2004) 1.44
Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism (2008) 1.43
Determinants of testosterone recovery after bariatric surgery: is it only a matter of reduction of body mass index? Fertil Steril (2013) 1.41
Perceived ejaculate volume reduction in patients with erectile dysfunction: psychobiologic correlates. J Androl (2010) 1.41
Thoracic kyphosis and ventilatory dysfunction in unselected older persons: an epidemiological study in Dicomano, Italy. J Am Geriatr Soc (2004) 1.37
Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials. Diabetes Care (2008) 1.33
Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care (2007) 1.32
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials. Eur J Endocrinol (2009) 1.30
Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract (2008) 1.30
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol (2009) 1.25
Reduced cardiocirculatory complications with unrestrictive visiting policy in an intensive care unit: results from a pilot, randomized trial. Circulation (2006) 1.24
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract (2007) 1.23
Metformin and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care (2010) 1.22
Predictive validity of measures of comorbidity in older community dwellers: the Insufficienza Cardiaca negli Anziani Residenti a Dicomano Study. J Am Geriatr Soc (2006) 1.15
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care (2008) 1.14
Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab (2011) 1.14
Glucagon-like peptide-1 receptor agonists and cardiovascular events: a meta-analysis of randomized clinical trials. Exp Diabetes Res (2011) 1.12
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke (2007) 1.12
Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care (2007) 1.12
Metformin beyond diabetes: new life for an old drug. Curr Diabetes Rev (2006) 1.11
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol (2013) 1.10
Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med (2014) 1.10
Diagnostic crossover and outcome predictors in eating disorders according to DSM-IV and DSM-V proposed criteria: a 6-year follow-up study. Psychosom Med (2011) 1.08
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. Prostate (2012) 1.07
Effects of glucagon-like peptide-1 receptor agonists on body weight: a meta-analysis. Exp Diabetes Res (2012) 1.06
Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials. Diabetes Metab Res Rev (2011) 1.05
The metabolic syndrome in treatment-seeking obese persons. Metabolism (2004) 1.00
Finger sepsis in two poorly controlled diabetic patients with reuse of lancets. Diabetes Care (2002) 0.99
Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J Sex Med (2009) 0.99
Cystatin C reference values and aging. Clin Biochem (2006) 0.99
Correlations between binge eating and emotional eating in a sample of overweight subjects. Appetite (2009) 0.99
Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med (2008) 0.99
Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med (2007) 0.98
The association between varicocele, premature ejaculation and prostatitis symptoms: possible mechanisms. J Sex Med (2009) 0.98
Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med (2009) 0.97
Serum PSA as a predictor of testosterone deficiency. J Sex Med (2013) 0.96
Are comorbidity indices useful in predicting all-cause mortality in Type 2 diabetic patients? Comparison between Charlson index and disease count. Aging Clin Exp Res (2007) 0.96
Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials. Int J Cardiol (2009) 0.95
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer. Lab Invest (2008) 0.94
Restoration of cardiomyocyte functional properties by angiotensin II receptor blockade in diabetic rats. Diabetes (2004) 0.94
The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction. J Sex Med (2009) 0.93
Sex-related differences in the length of disability prior to death in older persons. Aging Clin Exp Res (2003) 0.93
Post-prandial glucose and diabetic complications: systematic review of observational studies. Acta Diabetol (2011) 0.93
Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med (2010) 0.93
Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. J Sex Med (2009) 0.92
Aggressiveness, anger and eating disorders: a review. Psychopathology (2006) 0.92
Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis. Diabetes (2011) 0.92
Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol (2012) 0.91
Comparison of individual and group cognitive behavioral therapy for binge eating disorder. A randomized, three-year follow-up study. Appetite (2010) 0.90
The diabetic person beyond a foot ulcer: healing, recurrence, and depressive symptoms. J Am Podiatr Med Assoc (2008) 0.90
Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction. J Androl (2006) 0.90
Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials. Adv Ther (2012) 0.90
Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract (2007) 0.90
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats. Cardiovasc Diabetol (2009) 0.90
Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells. Biochem Biophys Res Commun (2003) 0.90
Thiazolidinediones and cancer: results of a meta-analysis of randomized clinical trials. Acta Diabetol (2013) 0.89
Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med (2009) 0.89
Different modulation of dipeptidyl peptidase-4 activity between microvascular and macrovascular human endothelial cells. Acta Diabetol (2010) 0.88
Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions. J Androl (2006) 0.88
Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks? Adv Ther (2012) 0.88
NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med (2007) 0.88
How to recognize late-onset hypogonadism in men with sexual dysfunction. Asian J Androl (2012) 0.87
Personality features of obese women in relation to binge eating and night eating. Psychiatry Res (2012) 0.87
Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. J Sex Med (2015) 0.87
Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study. Diabetes Metab Res Rev (2006) 0.87
Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). BMC Med Res Methodol (2013) 0.87
Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med (2007) 0.87
Effect of comorbidity on coronary reperfusion strategy and long-term mortality after acute myocardial infarction. Am Heart J (2006) 0.86
Bone: incretin hormones perceiver or receiver? Exp Diabetes Res (2012) 0.86
Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med (2010) 0.86
Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. J Sex Med (2008) 0.86